Vaccine Development Progress: Positive clinical trial results typically boost the stock price, while setbacks can cause a decline.

Regulatory Approvals: FDA approval or rejection significantly impacts the stock's value. Approval suggests future revenue potential.

Manufacturing and Distribution: The company's ability to manufacture and distribute vaccines effectively influences investor confidence.

Competition: The emergence of competing vaccines or treatments can negatively affect VAXX.US's market share and stock price.

Government Contracts and Funding: Receiving government contracts or research grants can positively influence the stock price.

Pandemic Trends: Changes in the severity and spread of infectious diseases affect demand for vaccines and thus the stock's performance.

Investor Sentiment: Overall market conditions and investor confidence in the biotechnology sector play a role.

News and Media Coverage: Positive or negative news reports about the company or its vaccines can influence investor behavior.

Financial Performance: The company's revenue, earnings, and profitability directly affect the stock price.